In cerebrally infarcted rats, Klotho has also been shown to improve neurological function, reduce ischemic injury, and reduce the area of cerebral infarction by inhibiting the p38 MAPK pathway by downregulating the expression of aquaporin 4 (AQP4) (143). The gene discussed is AQP4; the disease is brain infarction.